The Paras Health IPO 2026 opened for subscription on 21 October and closes on 23 October, with a price band of ₹660 to ₹693 per share for an issue of ₹1,450 crore. Of that, ₹500 crore is a fresh issue of shares and ₹950 crore is an offer for sale by existing shareholders. This explainer walks through the issue terms and shows how to read each part of an IPO, using Paras Health as the example, so that readers can understand the structure before looking at the offer documents. It is news reporting and education, not a recommendation to apply, and it does not use grey-market indicators.
Paras Health IPO 2026: key dates and terms
- Subscription: 21 to 23 October 2026; allotment tentatively 26 October; listing on BSE and NSE tentatively 28 October.
- Price band ₹660 to ₹693 per share; bids in lots of 21 shares, so one lot is ₹14,553 at the upper band (our arithmetic).
- Issue size ₹1,450 crore: ₹500 crore fresh issue plus ₹950 crore offer for sale.
- Reported use of fresh proceeds: ₹320.90 crore to repay company borrowings and ₹54.10 crore for a subsidiary’s borrowings, a total of ₹375 crore, with the balance for general corporate purposes.
- All dates and terms are as reported and can change; the prospectus is the authority.
The Paras Health IPO 2026 at a glance
Paras Healthcare is a Gurugram-based company that runs eight hospitals under the Paras Health brand, according to published summaries of its offer documents. The book-running lead managers are JM Financial, BofA Securities India and Nuvama Wealth Management, and the registrar is MUFG Intime India. The shares are proposed to list on BSE and NSE. Offer documents are filed with the regulator and posted on the NSE offer-documents page, and the Securities and Exchange Board of India and BSE sites are the places to check for updates.
What fresh issue and offer for sale mean
This section is general background. In a fresh issue, the company creates new shares and receives the money. In an offer for sale, existing shareholders sell shares they already hold and receive the money themselves. Paras Health’s ₹950 crore offer for sale is reported to comprise up to ₹300 crore by promoter Dharminder Kumar Nagar and up to ₹650 crore by Commelina. By our arithmetic, about 34% of the issue is fresh and about 66% is an offer for sale, which means most of the money raised goes to selling shareholders and not to the company.
Where Paras Health IPO 2026 fresh money is meant to go
According to summaries of the red herring prospectus, ₹320.90 crore of the fresh issue is meant to repay or prepay certain borrowings of the company and ₹54.10 crore is meant to support repayment of borrowings at a wholly owned subsidiary, a total of ₹375 crore. One summary projects the debt-to-equity ratio to fall from 2.00 times to 1.15 times, which is a company projection reported second-hand.
The anchor round in the Paras Health IPO 2026
Reports published on 21 October say the company raised ₹652.5 crore from 39 anchor investors at ₹693 per share, the top of the band, and name SBI Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mutual Fund, Abu Dhabi Investment Authority and BlackRock among them. That is about 45% of the total issue by our arithmetic. Anchor investors are large institutions that commit before the public opening, and their participation is a data point, not a guarantee about the issue’s performance.
The business behind the Paras Health IPO 2026
The company says it was founded in 1987 and operates eight hospitals with 2,211 beds across North India, Bihar and Jharkhand, with a 300-bed hospital planned in Gurugram and a 500-bed facility planned in Ludhiana, according to the summaries. Restated consolidated figures reported for the issue show total income of ₹1,314.21 crore in FY25 and ₹1,628.78 crore in FY26, and a loss of ₹57.98 crore in FY25 against a profit of ₹43.83 crore in FY26. These figures come from published summaries and should be checked against the prospectus.
Reading the Paras Health IPO 2026 numbers
This section is our analysis. A profit of ₹43.83 crore on income of ₹1,628.78 crore is a margin of about 2.7%, and total borrowing is reported at ₹1,393.86 crore at March 2026 against a net worth of ₹394.94 crore. Those two facts help explain why debt repayment is the main use of proceeds. A summary of the issue also puts the market capitalisation at the offer price at about ₹7,498 crore after the issue. We do not value the shares or say whether the price is high or low.
How applying to the Paras Health IPO 2026 works, in general
General background: investors place bids within the price band through a broker or bank, in lots, and money is blocked in the bank account until allotment. If demand exceeds the shares on offer, allotment is by rules for each investor category, and not everyone receives shares. Readers should check the category limits, the allotment date and the listing date in the prospectus and with their intermediary. Subscription figures change by the hour, and we do not quote them without an exchange timestamp.
What we have not covered on the Paras Health IPO 2026
- Grey-market premium or listing-day forecasts, which are unofficial and not reliable indicators.
- Live subscription numbers.
- A valuation or recommendation.
- Hospital-sector comparisons beyond what the summaries state.
Risks and caveats on the Paras Health IPO 2026
- About two-thirds of the issue is an offer for sale, so most proceeds go to sellers.
- The company reported a loss in FY25 and a profit only in FY26, and borrowings are high relative to net worth.
- Expansion plans depend on new hospitals being built and ramped up.
- Hospital businesses depend on doctor availability, regulation and payer mix, which we have not assessed.
- This is news reporting, not investment advice.
In our assessment, the Paras Health IPO 2026 is best read as the listing of a regional hospital chain that has just turned profitable and is using new money mainly to cut debt, and readers should base any decision on the prospectus, not on summaries or unofficial indicators. See also Sahajanand Medical Technologies IPO Closes Today: Price Band, Issue Size and Business Explained. More in our healthcare services coverage. The company describes itself on its company’s website.
What to watch next on the Paras Health IPO 2026
- Final subscription figures at close on 23 October.
- The allotment and listing dates.
- The first quarterly results after listing.
Frequently asked questions
When does the Paras Health IPO close?
On 23 October 2026, after opening on 21 October.
What is the price band?
₹660 to ₹693 per share, with bids in lots of 21 shares.
How much is fresh issue and how much is offer for sale?
₹500 crore is a fresh issue and ₹950 crore is an offer for sale, for a total of ₹1,450 crore.
How we reported this: we relied on published summaries of the offer documents and anchor-round reports of 21 October 2026, and we point readers to the exchange and regulator pages for the filings. Our arithmetic and general background are labelled. Last updated: 21 October 2026. This article is news reporting and education and not investment advice.
